Ion Exchange Q1 FY27 Results: Revenue +20%, PAT -94%

Earnings date and headline takeaway

Ion Exchange (India) Ltd’s latest earnings update is dated 5 August 2026 for Q1 FY27 (quarter ended June 30, 2026). The same dataset also lists 5 August 2026 as the “upcoming earnings date,” indicating the date is being used as the reported earnings date in the source. The numbers show a familiar pattern seen across several project and solution-led industrial companies: healthy top-line growth, but profitability compression.

On a consolidated basis, total income increased year-on-year, while profit after tax (PAT) fell sharply. The company also disclosed a segment realignment effective April 1, 2026, which changes how investors should read divisional performance going forward.

Q1 FY27 performance at a glance

For Q1 FY27, the dataset reports consolidated total income of ₹706.41 crore, up from ₹580.00 crore in the corresponding quarter last year. Consolidated revenue from operations is shown at ₹700.46 crore, compared with ₹583.19 crore in Q1 FY26, implying 20.11% YoY growth.

Profitability, however, weakened materially. Consolidated PAT is reported at ₹3.06 crore versus ₹48.70 crore (also stated as ₹48.44 crore in one place) in the year-ago quarter, a decline of about 93.7% YoY. Another summary snapshot in the dataset also mentions a net profit of ₹2 crore, but the detailed quarterly table shows net income of ₹4.11 crore and the consolidated filing highlights PAT of ₹3.06 crore.

Operating profit and margins: what the data shows

The Q1 highlights list operating profit of ₹9.99 crore on a YoY comparison basis, down 80.13%. The same highlight block puts the operating margin at 1.43%, down 83.46% YoY. In the quarterly table, operating income is ₹9.99 crore for Jun 2026 versus ₹50.28 crore for Jun 2025.

The dataset also provides an EBITDA comparison table: EBITDA of ₹31.70 crore in Q1 FY27 versus ₹62.50 crore in Q1 FY26, a decline of 49.28%, with EBITDA margin at 4.53% versus 10.72% (a contraction of 619 bps).

Consolidated vs standalone: earnings were supported by standalone

The standalone and consolidated trajectories diverged in the disclosed figures. Standalone total income is stated at ₹648.80 crore, with standalone PAT of ₹11.40 crore for the quarter. On the consolidated side, PAT is ₹3.06 crore.

The detailed standalone note in the dataset states:

• Standalone Q1 FY27 revenue from operations: ₹635.56 crore (₹63,556 lacs)
• Standalone Q1 FY27 PAT: ₹11.40 crore (₹1,140 lacs)
• Standalone basic and diluted EPS: ₹0.927

For consolidated results, the dataset states:

• Consolidated Q1 FY27 revenue from operations: ₹700.46 crore (₹70,046 lacs)
• Consolidated Q1 FY27 total income: ₹706.41 crore (₹70,641 lacs)
• Consolidated Q1 FY27 PAT: ₹3.06 crore (₹306 lacs)
• Consolidated basic and diluted EPS: ₹0.347

Quarter-on-quarter movement: revenue down, costs also eased

Sequentially, the quarter saw a decline in revenue versus the immediately preceding quarter (Mar 2026). The quarterly table shows total revenue of ₹700.46 crore in Jun 2026 versus ₹863.27 crore in Mar 2026, a -18.86% QoQ change.

Costs also moved down in step with the top line. Total operating expense is listed at ₹690.47 crore for Jun 2026 versus ₹862.92 crore for Mar 2026, a -19.98% QoQ shift. Despite lower expenses, profits remained under pressure, reflecting weak operating leverage and the margin squeeze highlighted in the operating margin and EBITDA margin metrics.

Cost lines and profit bridge indicators

A few line items in the quarterly table point to where pressure built:

• Depreciation and amortization: ₹21.75 crore (Jun 2026) vs ₹12.26 crore (Jun 2025), a 77.41% YoY increase.
• Selling, general and admin (SG&A): ₹108.62 crore vs ₹96.13 crore, up 12.99% YoY.
• Other operating expenses: ₹113.22 crore vs ₹80.94 crore, up 39.88% YoY.

The table also reports net income before taxes of ₹7.40 crore in Jun 2026 versus ₹65.92 crore in Jun 2025, indicating that the profitability decline is visible even before tax.

Segment realignment effective April 1, 2026

Ion Exchange stated it realigned its reporting segments effective April 1, 2026. The new segments are:

• Treatment Solutions
• Industrial Products
• Lifecycle Services
• Specialty Chemicals
• Consumer Products

In the segment disclosures included in the dataset (Q1 FY27), these values are specifically stated:

• Standalone Treatment Solutions revenue from operations: ₹201.00 crore (₹20,100 lacs), segment result ₹18.26 crore (₹1,826 lacs)
• Consolidated Treatment Solutions revenue from operations: ₹209.88 crore (₹20,988 lacs), segment result -₹17.35 crore (₹1,735 lacs loss)
• Industrial Products revenue from operations: ₹105.13 crore (₹10,513 lacs), segment result ₹12.48 crore (₹1,248 lacs)
• Specialty Chemicals revenue from operations: ₹229.65 crore (₹22,965 lacs), segment result ₹22.27 crore (₹2,227 lacs)

Regulatory and other disclosures in the dataset

The dataset references a SEBI deposit order of ₹22.02 crore and a SAT hearing date of August 12, 2026. While the financial impact is not quantified beyond the deposit amount, such disclosures are typically monitored by investors for potential cash outflows, timeline risk, and compliance-related uncertainty.

The dataset also notes that results include an exceptional item described as “Impact of Labour Codes” for the year ended March 31, 2026: ₹14.54 crore (standalone) and ₹16.89 crore (consolidated). These are not described as Q1 FY27 exceptional charges, but they are part of the broader disclosure package.

Key numbers table: Q1 FY27 snapshot

Market impact: what changes for investors and trackers

For quarter-on-quarter tracking, the reported -18.86% QoQ decline in total revenue and -19.98% QoQ decline in total operating expense signal that activity levels were lower than the March quarter in the dataset’s series. For year-on-year watchers, the key contrast is between revenue growth of around 20% and the much sharper decline in PAT.

The reported EPS compression mirrors this. The quarterly table lists diluted normalized EPS of 0.35 in Jun 2026 versus 4.11 in Jun 2025, down 91.55% YoY. Separately, the disclosed basic and diluted EPS values for Q1 FY27 are 0.927 (standalone) and 0.347 (consolidated).

Why the quarter matters in context

The dataset includes a reference point from Q3 FY25, stating a 6.1% QoQ increase in consolidated revenues and EPS of 4.1 in that quarter. Against that backdrop, the current quarter’s low EPS and margin compression underline how quickly earnings can swing when operating costs move faster than revenue.

The dataset also states that for the full year FY2026–2027, revenue reached ₹3,001.41 crore and profit touched ₹141.5 crore. This provides an additional context line in the same information pack, although the quarter-specific analysis remains centered on the Q1 FY27 figures and the disclosed cost and margin metrics.

Conclusion

Ion Exchange (India) delivered strong YoY growth in Q1 FY27 consolidated income, but the quarter was defined by sharp pressure on profitability, with consolidated PAT reported at ₹3.06 crore. The company’s segment realignment effective April 1, 2026 also resets how investors should track divisional performance.

The next dated milestone in the dataset is the SAT hearing on August 12, 2026, along with follow-through disclosures tied to the SEBI deposit order of ₹22.02 crore and any further clarification on operating cost trends in subsequent quarters.